blog
IVD Directive to IVD Regulation (EU 2017/746) Transition – 8 Months Remaining
IVD Regulation Postponement Today 14th October 2021 the European Commission has issued a Question and Answers press release on the…
News
VCLS Appoints Dr. Linsen Du as General Manager of China
Paris, France, September 6th, 2021 Voisin Consulting Life Sciences (VCLS), a leading global regulatory science and clinical consultancy company from…
News
VCLS announces the acquisition of Quanta Medical
Paris, June 1st, 2021 – Voisin Consulting Life Sciences (VCLS), a leading global HealthTech product development consultancy company, today announced…
News
VCLS announces today partnership agreement with iliomad Health Data
Paris, September 14th 2020 – Voisin Consulting Life Sciences (VCLS), a leading global HeathTech product development consultancy, today announced a…
News
Exclusive Interview with Biotech Finance: Biotechs and medtech, refine your pricing strategy and don’t work…
Emmanuelle Voisin, Founder, and CEO of Voisin Consulting Life Sciences is an expert in regulatory sciences and market access. In…
News
VCLS Acquires IWA Consulting ApS to Further Strengthen its Capacities in the Northern Europe
Paris, France, July 5th, 2019 We are delighted to announce that we have completed the acquisition of IWA Consulting ApS…
News
VCLS, Voisin Consulting Life Sciences announces strategic alliance with Worms Safety
Voisin Consulting Life Sciences (VCLS) and Worms Safety have announced that they have formed a strategic alliance. Through this partnership,…
News
VCLS Appoints Dr. Gopalan Narayanan, Vice-President, Disruptive Biologics
Previously head of the MHRA’s Biologicals unit, Dr. Narayanan provides strategic advice to leading developers of complex biologics, in particular…
